Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 11/20 | 0.59 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.47 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.47 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.45 |
| ▸ | CCR2 | P41597 | 1/20 | 0.45 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.44 |
| ▸ | CNR1 | P21554 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6440151 | 0.91 | F10 (0.72) | F10MTNR1AMTNR1BCCR2CNR1 | |
| SCHEMBL6432403 | 0.84 | CCR2 (0.50) | F10ROCK2CCR2NPY5RCNR1 | |
| SCHEMBL6433022 | 0.83 | F10 (0.65) | F10MTNR1AMTNR1BCCR2 | |
| SCHEMBL6433274 | 0.83 | F10 (0.74) | F10MTNR1AMTNR1BROCK2CCR2 | |
| SCHEMBL6435685 | 0.82 | F10 (0.71) | F10MTNR1AMTNR1BCCR2 | |
| SCHEMBL6433700 | 0.82 | CCR2 (0.54) | F10MTNR1AMTNR1BCCR2 | |
| SCHEMBL6433546 | 0.81 | CCR2 (0.67) | F10MTNR1AMTNR1BCCR2 | |
| SCHEMBL6432347 | 0.80 | F10 (0.61) | F10MTNR1AMTNR1BCCR2 | |
| SCHEMBL6432441 | 0.75 | F10 (0.58) | F10ROCK2CCR2CNR1 | |
| SCHEMBL6434382 | 0.72 | F10 (0.51) | F10ROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1042287-B1 | INDOLE DERIVATIVES AS INHIBITORS OF FACTOR XA | AVENTIS PHARMA GMBH (DE) | 2005-04-20 | — | — | EP | disclosed |
| US-6337344-B1 | ANTICOAGULANTS AND ENZYME INHIBITORS FOR CARDIOVASCULAR DISORDERS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-01-08 | — | — | US | disclosed |
| EP-1042287-A1 | INDOLE DERIVATIVES AS INHIBITORS OF FACTOR XA | Aventis Pharma Deutschland GmbH (DE) | 2000-10-11 | — | — | EP | disclosed |
| WO-1999033800-A1 | INDOLE DERIVATIVES AS INHIBITORS OR FACTOR XA | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 1999-07-08 | — | — | WO | disclosed |